Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual
- 30 September 2011
- journal article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 18 (5) , 587-591
Abstract
Background: Previous studies have demonstrated that intrathecal synthesis of IgM is observed in multiple sclerosis (MS) and correlates with a worse disease course. These results suggest that IgM participates in the formation of MS lesions.Keywords
This publication has 25 references indexed in Scilit:
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluidMultiple Sclerosis Journal, 2009
- Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?Neurology, 2008
- Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosisBrain, 2008
- Influence of oligoclonal IgM specificity in multiple sclerosis disease courseMultiple Sclerosis Journal, 2007
- Intrathecal IgM‐synthesis does not correlate with the risk of relapse in patients with a primary demyelinating eventEuropean Journal of Neurology, 2007
- Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”Annals of Neurology, 2005
- Intrathecal IgM synthesis is a prognostic factor in multiple sclerosisAnnals of Neurology, 2002
- Rating neurologic impairment in multiple sclerosisNeurology, 1983